{
    "startDate": "2019-01-01",
    "endDate": "2019-12-31",
    "year": "2019",
    "quarter": "FY",
    "symbol": "AVEO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 29785000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 17960000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1631000
            },
            {
                "label": "Clinical trial retainers current.",
                "concept": "aveo:ClinicalTrialRetainersCurrent",
                "unit": "usd",
                "value": 589000
            },
            {
                "label": "Other prepaid expenses and other assets current.",
                "concept": "aveo:OtherPrepaidExpensesAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 635000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 50600000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 50600000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1466000
            },
            {
                "label": "Accrued clinical trial costs and contract research current.",
                "concept": "aveo:AccruedClinicalTrialCostsAndContractResearchCurrent",
                "unit": "usd",
                "value": 5680000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2336000
            },
            {
                "label": "Loans payable, net of discount",
                "concept": "LoansPayableCurrent",
                "unit": "usd",
                "value": 9569000
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 1974000
            },
            {
                "label": "Deferred research and development reimbursement current.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementCurrent",
                "unit": "usd",
                "value": 93000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 21118000
            },
            {
                "label": "Loans payable, net of current portion and discount",
                "concept": "LongTermLoansPayable",
                "unit": "usd",
                "value": 6197000
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 2552000
            },
            {
                "label": "PIPE Warrant liability (Note 7)",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 5097000
            },
            {
                "label": "Other liabilities (Note 5)",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 790000
            },
            {
                "label": "Liabilities and stockholders\u2019 equity (deficit)",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 35754000
            },
            {
                "label": "Preferred stock, $.001 par value: 5,000 shares authorized at December 31, 2019 and December 31, 2018; no shares issued and outstanding at each of December 31, 2019 and December 31, 2018",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.001 par value: 50,000 shares authorized and 16,082 shares issued and outstanding at December 31, 2019; 25,000 shares authorized and 12,648 shares issued and outstanding at December 31, 2018",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 161000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 600306000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -585621000
            },
            {
                "label": "Stockholders' equity (deficit):",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 14846000
            },
            {
                "label": "Liabilities and stockholders\u2019 equity (deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 50600000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 9388000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2358000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "PaidInKindInterest",
                "unit": "usd",
                "value": 567000
            },
            {
                "label": "Non-cash change in fair value of PIPE warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": -11577000
            },
            {
                "label": "Amortization of premium and discount on investments",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 44000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -1395000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 742000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -2033000
            },
            {
                "label": "Increase decrease in accrued clinical trial costs and contract research.",
                "concept": "aveo:IncreaseDecreaseInAccruedClinicalTrialCostsAndContractResearch",
                "unit": "usd",
                "value": -574000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": -362000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -934000
            },
            {
                "label": "Increase decrease in deferred research and development reimbursement.",
                "concept": "aveo:IncreaseDecreaseInDeferredResearchAndDevelopmentReimbursement",
                "unit": "usd",
                "value": -361000
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -2919000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 17917000
            },
            {
                "label": "Investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -17917000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants net of issuance costs.",
                "concept": "aveo:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts",
                "unit": "usd",
                "value": 25279000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants to related parties.",
                "concept": "aveo:ProceedsFromIssuanceOfCommonStockAndWarrantsToRelatedParties",
                "unit": "usd",
                "value": 5000000
            },
            {
                "label": "Proceeds from issuance of stock for stock-based compensation arrangements",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 49000
            },
            {
                "label": "Payment on principal of loan payable (Note 6)",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 3834000
            },
            {
                "label": "Payment of loan maturity fees (Note 6)",
                "concept": "PaymentsOfDebtExtinguishmentCosts",
                "unit": "usd",
                "value": 300000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 26194000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 5358000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 1971000
            }
        ],
        "ic": [
            {
                "label": "Revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 28795000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 17958000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 11211000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 29169000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -374000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1815000
            },
            {
                "label": "Change in fair value of PIPE Warrant liability",
                "concept": "AdjustmentOfWarrantsGrantedForServices",
                "unit": "usd",
                "value": -11577000
            },
            {
                "label": "Other income (expense), net:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 9762000
            },
            {
                "label": "Net income (loss) before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 9388000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net income (loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 9388000
            },
            {
                "label": "Basic net income (loss) per share:",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 0.61
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 15331000
            },
            {
                "label": "Diluted net income (loss) per share:",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 0.61
            },
            {
                "label": "Weighted average number of common shares outstanding and dilutive share equivalents outstanding",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 15376000
            },
            {
                "label": "Unrealized (loss) gain on available-for-sale securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 9387000
            }
        ]
    }
}